Inflammopharmacology
Title Abbreviation
Inflammopharmacology
Electronic ISSN
1568-5608
Readership
Dermatologists, Gastroenterologists, Immunologists, Neurologists, Pharmacologists, Physicians, Physicians - Medicine, Pulmonologists, Rheumatologists, Toxicologists
Scope
Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has 7 main areas: Drug-Disease Interactions - Conditional Pharmacology; Rheumatology; Gastroenterology; Neuro-Inflammation and Pain; Novel drugs, natural products and nutraceuticals; Muscle-immune interactions during inflammation; Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics.
Sponsoring Association(s)
Hungarian Experimental and Clinical Pharmacology Society (HECPS), International Union of Basic and Clinical Pharmacology (IUPHAR)
Publisher Name
Springer Science and Business Media
Impact Factor
JCR Categories/Rank
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines